CLINICAL_TRIALS
trial_result
· 2026-08-11
Clinical Trial Results: Study of ExoFlo for the Treatment of Perianal Fistulas [Phase 1, Phase 2]
Summary
Phase 1/2 study evaluating ExoFlo for perianal fistulas in Crohn's disease; trial has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Direct Biologics, LLC | Conditions: Perianal Fistula, Crohn's Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-11